Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
580 trials across Europe, recruiting first
Study on Balcinrenone and Dapagliflozin for Adults with Chronic Kidney Disease and Albuminuria
AustriaStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
CzechiaStudy of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
Austria
BelgiumA study to evaluate the effect of baxdrostat and dapagliflozin in reducing protein in the urine for patients with chronic kidney disease and high blood pressure
BulgariaStudy of nedosiran for patients with primary hyperoxaluria type 1 and severe kidney impairment with or without dialysis
GermanyA Study of ALXN1920 Compared to Placebo in Adults with Primary Membranous Nephropathy at High Risk for Disease Progression
FranceBelgiumA study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease
BelgiumA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
Belgium
PolandStudy of N-803 combined with BCG treatment for patients with early-stage bladder cancer that has not invaded the muscle wall
GermanyThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
